Hostname: page-component-8448b6f56d-gtxcr Total loading time: 0 Render date: 2024-04-19T22:33:20.068Z Has data issue: false hasContentIssue false

Epidemiology of Parkinson’s Disease

Published online by Cambridge University Press:  18 September 2015

A.H. Rajput*
Affiliation:
Department of Clinical Neurological Sciences, University Hospital, Saskatoon
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Epidemiology of parkinsonism for 13 years (1967 to 1979) in Rochester, Minnesota is evaluated. For each patient, two age- and sex-matched controls with comparable medical follow-up (mean 40 years before diagnosis) were selected from the same community. Smoking habits, dementia, acute and chronic illnesses and mortality patterns in the two groups are compared. The annual incidence rate was 20.5/100,000, which is virtually unchanged from previous reports on Rochester population. Cigarette smoking habits of cases and the controls before the index date were not significantly different. Prior to diagnosis of Parkinson’s disease, dementia was diagnosed significantly more frequently among the patients than the controls (P = 0.048). After diagnosis of parkinsonism dementia emerged nearly three times more frequently in patients than among the controls. Mortality rate in the entire parkinsonian population was similar to that reported from the same community between 1935 and 1966. Only 50% of the patients were treated with levodopa. Among those treated with levodopa the mortality rate was comparable to their controls. Because there were no definite criteria for administering levodopa therapy, higher frequency of dementia and prolonged survival in those treated with this drug could be attributed to the bias of case selection for treatment.

Type
3. Genetic Factors and Epidemiology of Parkinson’s Disease
Copyright
Copyright © Canadian Neurological Sciences Federation 1984

References

Baumann, RJ, Jameson, HD, McKean, HE, Haack, DG, Weisberg, LM (1980) Cigarette Smoking and Parkinson’s Disease. 1. A comparison of cases with matched neighours. Neurology 30:839–43.CrossRefGoogle Scholar
Cotzias, GC (1971) Levodopa in the Treatment of Parkinsonism. J.A.M.A. Vol. 218, No. 13: 19031908.CrossRefGoogle ScholarPubMed
Goetz, CG (1983) Drug-Induced Parkinsonism and Idiopathic Parkinson’s Disease. Arch. Neurol. 40:325326.CrossRefGoogle ScholarPubMed
Haack, DG, Baumann, RJ, McKean, HE, Jameson, HD, Turbeck, JA (1981) Nicotine Exposure and Parkinson’s Disease Amer. J. of Epidemiology 114:2:191200.CrossRefGoogle Scholar
Hammond, EC (1966) Smoking in Relation to the Death Rates of One Million Men and Women. In Epidemiological Study of Cancer and Other Chronic Disease. National Cancer Institute Monograph No. 19. Washington, D.C.: U.D. Government Printing Office: 127204.Google Scholar
Hoehn, MM, Yahr, MD (1967) Parkinsonism: Onset, Progression, and Mortality. Neurology, 17:427442.CrossRefGoogle ScholarPubMed
Kahn, HA (1966) Smoking in Relation to the Death Rates of One Million Men and Women. In Epidemiological Study of Cancer and Other Chronic Disease. National Cancer Institute Monograph No. 19. Washington, D.C.: U.S. Government Printing Office: 1125.Google Scholar
Kurland, LT (1958) Epidemiology: Incidence, Geographic Distribution, and Genetic Considerations. In Field, W. (ed.): Pathogenesis and Treatment of Parkinsonism. Charles C. Thomas, Springfield, Illinois: 543.Google Scholar
Nobrega, FT, Glattre, E, Kurland, LT, Okazaki, H (1967) Genetics and Epidemiology of Parkinson’s Disease. In Barbeau, A, Brunnette, JR (eds.): Progress of Neurogenetics. Excerpta Medica Foundation, Amsterdam: 474485.Google Scholar
Poskanzer, DC, Schwab, RS (1963) Cohort Analysis of Parkinson’s Syndrome: Evidence for a Single Etiology Related to Sub-Clinical Infection About 1920. J Chr. Dis. 16: 961973.CrossRefGoogle Scholar
Rajput, AH, Rozdilsky, B, Hornykiewicz, O, Shannak, K, Lee, T, Seeman, P (1982) Reversible Drug Induced Parkinsonism, Clinico-pathological Study of two cases. Arch. Neurol., 39:644646.CrossRefGoogle Scholar